Study, year [ ] Reference | Patients (n) | HIV-positive (%) | Virology result | |||||||
---|---|---|---|---|---|---|---|---|---|---|
>1 virus | Influenza virus | Adenovirus | Rhinovirus | PIV1-3 | RSV | hMPV | Other | |||
Joosting et al., 1979a [44] | 1012 | NS | 477 (47.1%) | Any: 384 (37.9%) A: 287 (28.4%) B: 87 (8.6%) C: 10(1.0%) | 45 (4.4%) | - | 17 (1.7%) | 8 (0.8%) | - | Enterovirus: 1 |
Scott et al., 2000b [8] | 281 | 52% | 16 (5.7%) | 5% A: 12 (4.3%) B: 2 (0.7%) | 2 (0.7%) | - | - | 0 | - | |
Hartung et al., 2011c [45] | 51 | 94% | 11 (21.6%) | A: 1 | 1 (9%) | 4 (36%)d | PIV1: 1 (9%) | 1 (9%) | Bocavirus: 1 (9%) Coronavirus NL63: 1 (9%); Coronavirus OC43: 1 (9%) | |
Feikin et al., 2012e [39] | 396f | 49% | 230 (58%) | Any: 37 (9%) A: 29 (7%) B: 8 (2%) | 29 (7%) | 39 (35%)h | PIV1: 2 (0.5%) PIV2: 6 (2.0%) PIV3: 14(4.0%) | 33 (8%) | 10 (3%) | |
Pretorius et al., 2012i [41] | 4006g | NS | 5–24 years: 51% 25–44 years: 33.8% 45–64 years: 28.7% >65 years: 24.2% | Any: 343 (8.6%) A(H3N2): 102 (2.5%) A(H1N1): 104 (2.6%) B: 137 (3.4%) | 251 (6.3%) | 653 (16%) | Any: 145 (3.4%) PIV1: 12 (0.3%) PIV2: 27 (0.7%) PIV3: 96 (2.4%) | 134 (3.3%) | 62 (1.5%) | Enterovirus: 63 (1.6%) |